Tyler Golato·Jul 11, 2023Introducing IP Tokens (IPTs): A New Incentive for Scientific Collaboration“Show me the incentive and I’ll show you the outcome” — Charlie Munger
Tyler Golato·Jan 28, 2022The Emergence of Biotech DAOsA blossoming Decentralized Science (DeSci) movement is changing the biopharma landscape by enabling the formation of patient- and…A response icon2A response icon2
Tyler Golato·Aug 19, 2021IP-NFTs for Researchers: A New Biomedical Funding ParadigmTL;DR: This week, the first university biomedical intellectual property (IP) and research project was funded as an NFT (non-fungible…
Tyler Golato·Oct 1, 2020Molecule and the Search for Longevity TherapeuticsIn a few short weeks, we will be launching one of our flagship longevity projects with the University of Copenhagen’s Center for Healthy…
Tyler Golato·Apr 24, 2020The Impact of COVID-19 on Science, Publishing, and Drug DevelopmentThe Defining Event of Our Lifetimes
Tyler Golato·Feb 10, 2020Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.The pharmaceutical industry is facing a wide variety of challenges, but perhaps the most pressing is the ongoing innovation crisis. Drug…
Tyler Golato·Jun 4, 2019Funding Late Stage Clinical Development of a Novel AntimalarialMolecule Case Study Series
Tyler Golato·Apr 9, 2019The Future of Drug Development is OpenPharma Macroeconomics: A Looming Crisis